Basic helfxloop-helix (bHLH) heterodimer protein complexes regulate transcrIption of genes during the processes of diferentiation and development. To 
cultured endothelial cells and in embryonic stem cell, erythroleukemia, and muscle cell ines in a differentation-dependent manner. In situ hybridization studies of mouse embryos reveal that bHLH-EC2 is essed throughout the pritive mesoderm as early as 7.5 days postcoitum. Expression then becomes restried to the p I mesoderm and to the dermamyotome of the developing somite. Expression of bHLH-EC2 in cells desi to become myoblasts thus predates expression of myogenic bHLH factors. bHLH-EC2 is expressed in early endothellal and hematopoletic cells in wivo, as shown by RNA studies of embryonic yolk sac and cultured cells derived from yolk sac explants. These fn g ugt that bHILH-EC2 plays a role In the development ofmultiple cell typs derived from the primitive mesoderm.
The mesodermal germ layer in vertebrates is formed at gastrulation by inductive interactions (1) (2) (3) . It is important to link the early molecular events ofmesodermal induction with the determination of specific cell types, which ultimately constitute tissues derived from the mesoderm. This can be accomplished only through the study of genes expressed in mesodermal cells at this critical developmental period. Study of the genes regulating differentiation of the mesoderm in model systems such as Drosophila has indicated that transcription factors of the basic helix-loop-helix (bHLH) class have an important role in fundamental early processes such as dorsoventral patterning (4) (5) (6) . Experiments in mammalian development concentrating on relatively late events, such as determination and differentiation of specific cell lineages, have also indicated that this class oftranscription factors has a singularly important role in regulating the development of mesodermal tissues. Four transcription factors of the bHLH class have been shown to activate the muscle-specific program in cells in culture, and recent gene targeting experiments have provided some insight into the regulatory network that links these transcription factors (7) (8) (9) . In addition, bHLH factors have been implicated in the differentiation of other mesodermally derived cell types, including those of hematopoietic lineage (10) (11) (12) .
In (18) . Cells from the murine yolk sac were derived as described but maintained in the presence of LIF instead of feeder layers (19) . RNA (Fig. 1A) . bHLH-EC2 is homologous in its bHLH domain to the developmental factor Twist and to several members of a family of bHLH factors identified through their location at breakpoints of chromosomal translocations associated with T-cell leukemias (Fig. 1B) (20) (21) (22) (23) . TALl and Lyll have been implicated in the normal differentiation ofhematopoietic cells (24) . Twist is the only one of these factors that has homology to bHLH-EC2 outside of the bHLH domain, because of a glycine-rich region located in both proteins between the N terminus and the bHLH domain (25) . There is minimal homology to the bHLH domains of the myogenic factors myoD and myogenin (Fig. 1B) .
Cell-Specfc Expression of bHLH-EC2. The expression of bHLH-EC2 was determined in a variety ofhuman cell lines by RNA blot analysis ( Fig. 2A) Genetics: Quertermous et al. To characterize further the expression pattern of the bHLH-EC2 gene, RNA blot analyses were performed on mouse tissues and established cell lines (Fig. 2B) . The partial mouse cDNA used as a probe in these studies does not contain the bHLH domain, thus making it unlikely to crosshybridize with transcripts from other genes on the basis of homology in the bHLH domain. There was no bHLH-EC2 message detected in organs from adult mice, including small intestine (gut), kidney, liver, heart, brain, testes, and lung. Developmntal-Spedfic Expre of bHLH-EC2. Embryonic expression of bHLH-EC2 was first evaluated by RNase protection assay with poly(A)+ RNA prepared from mouse embryos 9.5, 10.5, 11.5, and 13.5 d.p.c. and with yolk sacs isolated at 10.5 d.p.c. (Fig. 3A) . Embryos and yolk sacs were carefully dissected to prevent cross-contamination. High levels of bHLH-EC2 mRNA were present in 9.5-, 10.5-, and 11.5-d.p.c. embryos but the level of bHLH-EC2 mRNA diminished significantly by 13.5 d.p.c. bHLH-EC2 mRNA was expressed in the embryonic yolk sac at the single time point investigated.
To investigate the expression of bHLH-EC2 in the early embryo, we used an in vitro ES cell differentiation model. (18) . RNA isolated from D3 ES cells pre-and postdifferentiation was examined by an RNase protection assay (Fig. 3B) . ES cells expressed bHLH-EC2 at a low level in the undifferentiated state and expression markedly increased with differentiation. The induction of bHLH-EC2 expression declined by day 4 and there was no detectable expression after this time. A mouse P-actin probe was used to verify that this pattern of induction was not due to differences in RNA amount or integrity. Expression of bHLH-EC2 in the pluripotent ES cells and its immediate induction by differentiation suggest that bHLH-EC2 may be expressed very early in mouse development.
A detailed spatial and temporal analysis of bHLH-EC2 expression was obtained by in situ hybridization of sections of embryos between 7.5 and 11.5 d.p.c. (Fig. 4) . Expression of bHLH-EC2 was detected at the earliest stage that was analyzed, 7.5 d.p.c., and was found to be restricted to the intraembryonic mesoderm (Fig. 4 A-C) . There is no signal associated with the membranes or the maternal tissue included in the sections at this stage. Also, there is no expression in the neuroectoderm or the forming notochord. At 8.0-8.5 d.p.c., bHLH-EC2 is expressed in the condensing paraxial mesoderm and the early somite (Fig. 4 D-G . At this stage, there is evidence of a rostral-caudal pattern of expression (Fig. 4 F and G) . By 9.5 d.p.c., expression is confined to the somite and appears to be most prominent in the myotome and dermatome (Fig. 4 H and I) . At 10 d.p.c., bHLH-EC2 expression in the somite appears to have declined in the myotome but persists at a high level in the dermatome. No signal is detected in the sclerotome (Fig. 4 J  and K) . At 10.5 d.p.c., expression is seen only in somites in the caudal portion of the embryo (Fig. 4 L and M) . Because of similarity in the bHLH domain, the presence of a glycine-rich region, and early mesodermal expression, this bHLH factor appears most similar to the developmental factor twist. twist was initially characterized in Drosophila (twi) as one of the first zygotic genes necessary for mesoderm formation (26) . twi homologs have now been cloned and their expression patterns characterized in Xenopus and mouse (Twist) (25, 27) . Comparison of published in situ data for mouse Twist with that presented here for bHLH-EC2 reveals that these two genes have nonoverlapping patterns of expression (25) . While bHLH-EC2 is initially expressed throughout the mesoderm in the late primitive streak embryo, by the time mouse Twist expression begins bHLH-EC2 has localized to the paraxial mesoderm and the dermamyotome of the developing somite. Mouse Twist expression begins after evolution of the mesoderm into somites and is expressed in the sclerotome where bHLH-EC2 expression is absent. In addition, mouse Twist is expressed in the lateral mesoderm and mesodermally derived tissues in the head, while bHLH-EC2 expression remains restricted to the somites. Expression of these homologous bHLH factors thus appears to subdivide the mesoderm, suggesting that they may serve a similar developmental function in different cell lineages derived from the mesodermal germ layer. RNA (19) . It has been postulated that both hematopoietic and endothelial cell precursors derived from a single common progenitor, the hemangioblast (28 
